Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV001253738 | SCV001429596 | likely pathogenic | PGM1-congenital disorder of glycosylation | 2019-02-16 | criteria provided, single submitter | clinical testing | |
Equipe Genetique des Anomalies du Developpement, |
RCV001253738 | SCV001554496 | pathogenic | PGM1-congenital disorder of glycosylation | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001253738 | SCV003523300 | pathogenic | PGM1-congenital disorder of glycosylation | 2022-09-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 976429). This premature translational stop signal has been observed in individual(s) with phosphoglucomutase deficiency (PMID: 24499211). This variant is present in population databases (rs745993071, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg499*) in the PGM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PGM1 are known to be pathogenic (PMID: 22492991). |
Juno Genomics, |
RCV001253738 | SCV005415646 | pathogenic | PGM1-congenital disorder of glycosylation | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PM3_Supporting+PP4 |